Heterocyclic compounds as inhibitors of factor VIIa
申请人:Glunz W. Peter
公开号:US20060211720A1
公开(公告)日:2006-09-21
The present invention relates generally to compounds that inhibit serine proteases. In particular it is directed to novel heterocyclic compounds, or a stereoisomer or pharmaceutically acceptable salt, solvate, or prodrug form thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.
Palladium-catalyzed oxidative C–H/C–H cross-coupling of benzothiazoles with thiophenes and thiazoles
作者:Xuxing Chen、Xiaojing Huang、Qian He、Yuyuan Xie、Chunhao Yang
DOI:10.1039/c4cc00362d
日期:——
A concise palladium-catalyzed method for oxidative CâH/CâH cross-coupling between benzothiazoles and thiophenes/thiazoles has been developed. This CDC reaction is insensitive to air and moisture with high functional group tolerance.